Month: April 2020
-

Infographic – Biotech Remains Hottest Venture Sector
A report on venture capital investments for the first quarter of 2020 shows biotechnology companies remain the largest recipients of venture investor dollars.
-

Venture Deals Decline in Q1, Biotech Sizzles Again
The number of venture deals declined for the third straight quarter as 2020 opened, but biotechnology remained the hottest single sector for investors.
-

Moderna Gains $483M for Covid-19 Vaccine
A government preparedness agency awarded biotechnology company Moderna Inc. $483 million to advance its Covid-19 vaccine through clinical trials.
-

Covid-19 Antibody Therapy Prepares for Trial
A biotechnology company producing synthetic antibodies in cattle, without human blood, to treat Covid-19 infections is advancing the therapy toward a clinical trial.
-

Trial Testing Mechanical Ventilator Alternatives
A clinical trial in the U.K. is testing early steps to help the breathing of people hospitalized with Covid-19 infections to avoid later use of mechanical ventilators.
-

Analysis Shows Covid-19 Largely Contained in Iceland
Aggressive early testing combined with contact tracing and self-isolation in Iceland appears to be slowing the spread of Covid-19 infections, according to a genetic analysis.
-

Community Covid-19 Infection Study Underway
A study is underway to track Covid-19 infection patterns in homes and communities in the U.S. southeastern and middle-Atlantic states.
-

Stroke Speech Therapy App Gains Breakthrough Tag
A mobile app providing speech therapy exercises at home for people recovering from a stroke received a breakthrough device designation from FDA.
-

Covid-19 Saliva Sample Collection Cleared by FDA
A Covid-19 test procedure using saliva samples rather than specimens from the nose and throat received emergency clearance from the Food and Drug Administration.
-

Univ. Lab to Offer Large-Scale Covid-19 Testing
A University of Maryland lab will seek FDA authorization for its plan to provide high-volume detection testing for Covid-19 infections among state citizens.